Spun off from Novartis in 2019, Alcon is betting on new product launches to accelerate sales growth in the second half of ...

Tryptyr, a new dry eye treatment, is approved. Learn why Black participation in clinical trials is vital for effective, ...

Researchers share that perfluorohexylactane eye drops offer rapid relief for dry eye disease, enhancing patient comfort ...

For open-angle glaucoma or ocular hypertension well controlled by eye drops, secondary selective laser trabeculoplasty ...

Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S.

Whether they’re suffering from red, itchy eyes during allergy season, dealing with the discomfort of ear wax buildup or ...

The National Authority for Medicines and Health Products (Infarmed) has ordered the immediate suspension of the distribution ...

The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors.

But it’s Charisse Brown’s eye condition, glaucoma, that diminishes her vision. Brown, 38, has worked all her adult life, with ...

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first ...

The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...